Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
HelouMed from Maarkedal, company number BE0723767181, closed financial year 2025 with a result of € 464,382 after tax. For that financial year HelouMed recorded a gross margin of € 636,114 and equity of € 20,460. Compared with financial year 2024, the result moved from € 413,554 to € 464,382. Profitable, and profit is growing. The buffer shrank hard: equity is 95 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 20,460
▼ 95% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 464,382
▲ 12% vs 2024
Profit after tax over the fiscal year.
€ 171,321
▲ 58% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 885,599 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 41,778
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 126
▼ 89% vs 2024
Loans from banks and other lenders, long and short.
€ 15,377
▲ € 13,775 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,626
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 585,308 | € 592,890 | € 567,078 | € 636,114 | ▲ 12% |
| Profit after taxes | € 438,044 | € 434,665 | € 413,554 | € 464,382 | ▲ 12% |
| Equity | € 463,458 | € 498,123 | € 441,677 | € 20,460 | ▼ 95% |
| Total debts | € 4,282 | € 18,826 | € 6,263 | € 510,170 | ▲ € 503,907 |
| Cash | € 135,004 | € 80,429 | € 108,427 | € 171,321 | ▲ 58% |
| Retained profit | € 444,858 | € 479,523 | € 423,077 | € 1,860 | ▼ € 421,217 |
| Dividend | € 600,000 | € 400,000 | € 470,000 | € 885,599 | ▲ 88% |
| Bank debt | € 0 | € 0 | € 1,096 | € 126 | ▼ 89% |
| Balance sheet total | € 467,740 | € 516,949 | € 447,940 | € 530,630 | ▲ 18% |
Key figures of HelouMed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HelouMed?
What happened at HelouMed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 464,382 (▲ 12% vs 2024). Source: NBB ↗
- Frederik Helsen became a director. NBB
- New establishment in Maarkedal. KBO
- Sofie Louage became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 438,044 profit in 2022 to € 464,382 profit in 2025.
Paid € 570,059 in corporate taxes since 2022.
Best year ever: 2025, with € 464,382 profit.
Paid out € 2.4 million in dividends to the owners in total.
Management
Behind HelouMed are Frederik Helsen and Sofie Louage.
Directors
According to the 2025 annual accounts
Frederik Helsen
Director
since 2021
Sofie Louage
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Puttene 57
9680 Maarkedal
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0723.767.181
- VAT number
- BE 0723.767.181
- Registered office
- Puttene 57, 9680 Maarkedal
- Names & denominations
- HelouMed
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 March 2019
- Peppol
- Active · Active since 27 Aug 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.